February 23, 2018 / 1:46 PM / 3 months ago

BRIEF-Amgen Receives Positive Opinion Expanding Use Of Xgeva (Denosumab)

Feb 23 (Reuters) - Amgen Inc:

* AMGEN RECEIVES POSITIVE OPINION EXPANDING USE OF XGEVA® (DENOSUMAB) TO COVER PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA IN EUROPE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below